The NE/CAMP+aPD‐1 group showed a rapid therapeutic response after the first aPD‐1 administration, and complete tumor regression was observed in 50% of mice on Day 28 after tumor inoculation (Figure 2c). The gene discussed is CAMP; the disease is neoplasm.